Troponin I elevation as a marker of right ventricular dysfunction and severity in pulmonary embolism Background : 1.Cardiac troponin I (Ti) : a specific.

Slides:



Advertisements
Similar presentations
Cardiac conducting system. Learning Outcomes The heart beat originates in the heart itself but is regulated by both nervous and hormonal control. The.
Advertisements

British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Physical Education Studies
What is Blood pressure? HYDROSTATIC FORCE OF THE BLOOD ONTO THE WALLS OF THE BLOOD VESSEL (RESISTANCE)
Pulmonary Embolism Jeannette Corona. Title: Alteplase Treatment of Acute Pulmonary Embolism in the Intensive Care Unit Authors: Pamela L. Smithburger,
Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Diagnostic Stress Testing
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
Syncope & serial troponins don’t mix Cost Containment Project June 2015 Alex Raufi PGY2.
Biochemical Markers of Myocardial Infarction
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
1 *Report IIB(R) 27/ The CoStar Stent (Conor) was also tested but is not shown in this report as it only presents the commercially available stents.
Lymphatic System: Overview Figure 19.1a. Lymphatic System: Overview Consists of three parts –A network of lymphatic vessels –Lymph nodes scattered throughout.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Blood Circulation Physiology. Vascular System O Blood circulates inside blood vessels O Comprises the vascular system O Arteries O Carries blood AWAY.
BURZOTTA F. 1, PAN M. 2 (CO-FIRST AUTHOR), TRANI C. 1, MEDINA A. 3, SUÀREZ DE LEZO J. 2, NICCOLI G. 1, ROMERO M. 2, PORTO I. 1, MAZUELOS F. 2, LEONE A.M.
PULMONARY EMBOLI Kenney Weinmeister M.D.. PULMONARY EMBOLI w Over 500,000 cases per year. w Results in 200,000 deaths. w Mortality without treatment is.
Confidential: Internal Use only 1 Click to edit Master title style Click to edit Master text styles – Second level Third level – Fourth level » Fifth level.
Long-term Benefits of Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus on Right Ventricular Function Brent Keeling MD 1, Bradley G. Leshnower.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
1 ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION BY TISSUE DOPPLER IMAGING SHOWS EVIDENCE OF SUBCLINICAL CARDIOMYOPATHY EARLY AFTER ATHRACYCLINE THERAPY.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
Importance Of Proximal Angle And Interpolated Minimal Luminal Diameter In Coronary Bifurcation Lesions Bhaktha M.D. Maddhavapeddy Aditya M.D. Maddury Jyotsna.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Higher Human Biology. Blood Pressure  The force exerted by blood against the walls of the blood vessels  Measured in mmHg (millimetres of mercury) 
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Topic 1.2/1.3, Risk factors for CVD Blood Pressure and tissue fluid formation.
Pulmonary Embolism and the Role of Echocardiograms in Management
Prevalence of preserved left ventricular function among patients admitted for pulmonary oedema F.HAZIZA, N.COHEN, J.F.LANDAU, A.C.GUIOMARD. Service de.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Catheter Based Treatment of Pulmonary Embolisms
Total Occlusion Study of Canada (TOSCA-2) Trial
Invasive Assessment of Coronary Artery Disease
Catheter Based Treatment of PE
Diagnosing cardiac contusion : old wisdom and new insights
Summary and Conclusion
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.
OCT-Guided PCI What needs to be done to establish criteria?
On behalf of J. Belardi, M. Leon, L. Mauri,
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Intensive Observation Unit Careggi University Hospital, Firenze Italy
by Thomas H. Marwick, and Markus Schwaiger Circ Cardiovasc Imaging
Case of nonobstructive coronary artery disease of left anterior descending artery (LAD) and regional LV dysfunction detected on cardiac CT with subsequent.
Circ Cardiovasc Imaging
No Reflow Reflow P value Arrhythmia 40% 18% Lecture Notes
Pulmonary Embolism Doug Bretzing, pgy 3
Blood Pressure.
European Heart Association Journal 2007 April
Advancing Acute Coronary Syndrome Assessment:
Giuseppe Biondi Zoccai, MD
Moderate/intermediate risk
Division of Cardiovascular Diseases No relevant author disclosures
A C Segment 1 Segment B Segment 4 D 5 3
Gregory Piazza et al. JCIN 2015;8:
Correlation between endothelial function and hypertension
Presented at TCT 2006.
Impact of Diabetes Mellitus on Long-term Outcomes in the
Maintenance of Long-Term Clinical Benefit with
Biochemical Markers of Myocardial Infarction
Plaque Modification in Severe Coronary Artery Calcification by Lithoplasty (A) Angiography demonstrates a stenotic lesion in the mid right coronary artery,
Detection of Hemodynamically Significant Coronary Stenosis: CT Myocardial Perfusion versus Machine Learning CT Fractional Flow Reserve Myocardial blood.
Presentation transcript:

Troponin I elevation as a marker of right ventricular dysfunction and severity in pulmonary embolism Background : 1.Cardiac troponin I (Ti) : a specific marker for detection of minor myocardial cell damage. 2.Severe pulmonary embolism : The rise in pulmonary pressure can lead to progressive right ventricular dysfunction (RVD)–> the presence of ischemia and even right ventricular infarction Aims : To determine the prevalence and diagnostic utility of Ti in identifying pts with RVD and ascertain if it correlates with the severity of PE. S.Amorim et al, Hospital de S. Joao,Oporto,Portugal, 2002

Methods 1.77 pts with PE 2.Classified the PE in severity levels (by ESC) 1-massive : shock and /or hypotension 2-submassive : RV hypoplasia found by echo 3-nonmassive : the remaining cases 3. The highest Ti serum value : since the admission until 24 hours and a normal value of <0.10 ng/ml

Results 1.60 pts with Ti measurements : 42 (elevated Ti values) 2.Pts with RVD : 26 (81.3%) had increased Ti levels without RVD : only 14 (35%) with elevated Ti level  positive Ti test : significantly associated with RVD (P= 0.038) 3.Positive Ti test : earlier beginning of symptoms ( vs hours, p=0.02) 4.Positive Ti test : a higher prevalence of emboli in proximal vessels( pulmonary trunk and right or left pulmonary trunk) (92% vs 52%, p=0.012)

Results-2 1.The mean level of Ti : pts with severe PE ( ng/ml) vs submassive PE( ng/ml) vs nonmassive PE( ng/ml) (P=0.045) 2.The level of d-dimers or systolic pressure of pulmonary artery : no gradual relationship between the classes of PE.

Conclusions 1.Around 55% of pts with PE have elevated Ti. 2.Ti : significantly associated with RVD 3.Ti : identification of pts of greater severity and at increased risk of hemodynamic deterioration, which can benefit of more aggressive therapeutical strategies

Determinants of the expansion of different coronary stents in curved stenotic lesions :an in-vitro experimental study Background: 1.Coronary stent implantation in angulated vessels is a challenging issue 2.Currently lack of consensus regarding the type and length of stents best suitable for such lesion Aims : To assess comparatively the expansion parameters of several new generation stent types in a curved stenotic phantom. T. Poerner et al, University hospital of Manheim;Technical University,institut fur Biomedizinische Technik, Berline,Germany,2002

Methods 1.Identical silicon models of 3.2 mm diameter with a 55% concentric elastic stenosis 2.A number of 5 stents for each length and type: AVE (Medtronic ) /12, 3.5/18 mm Penta (Guidant) /13, 3.5/18 mm BX-Sonic (Cordis) /13, 3.5/18 mm FlexMaster (Jomed) /12, 3.5/16 mm

Methods-2 3.The forces exerted during ballon inflation (Finfl) and after ballon deflation (Fstent) : continuously registered at a rate of 20 measurements per second using a high sensitive dynamometer 4. MLD (minimal luminal diameter of stent) RLD (reference luminal diameter of stent) BDmin (minimal luminal diameter of inflated ballon) BDref (reference luminal diameter of inflated ballon) : were determinated by X –ray imaging with direct magnification

Results 1.All stents: a good wall apposition without deformation of the phantom curvature 2.The expansion parameters related to the stent length : no significant differences. 3.The displacement forces on the vessel : within a low range for all stents (higher for AVE and Penta) 4.Expansion parameters are summarized in the table below.

Parameter of stent expansion

Conclusions In this curved elastic stenotic model 1.AVE : the lowest recoil 2.AVE & Penta : reach the largest MLD 3.FlexMaster : the lowest expansion forces 4.FlexMaster & BX-Sonic : significant lower MLD values